Surgery Partners Stock Forecast, Price & News

+2.16 (+3.34 %)
(As of 06/21/2021 03:03 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume7,213 shs
Average Volume420,429 shs
Market Capitalization$4.01 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SGRY News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

Surgery Partners logo

About Surgery Partners

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through Surgical Facility Services and Ancillary Services segments. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2020, it owned or operated a portfolio of 127 surgical facilities, including 110 ambulatory surgical centers and 17 surgical hospitals in 30 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.18 out of 5 stars

Medical Sector

981st out of 2,101 stocks

General Medical & Surgical Hospitals Industry

5th out of 12 stocks

Analyst Opinion: 1.4Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions

Is Surgery Partners a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Surgery Partners stock.
View analyst ratings for Surgery Partners
or view top-rated stocks.

What stocks does MarketBeat like better than Surgery Partners?

Wall Street analysts have given Surgery Partners a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Surgery Partners wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Surgery Partners

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) posted its quarterly earnings results on Wednesday, May, 5th. The company reported ($0.30) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.30). The business earned $512.40 million during the quarter, compared to the consensus estimate of $505.22 million. Surgery Partners had a negative net margin of 5.67% and a negative trailing twelve-month return on equity of 3.68%.
View Surgery Partners' earnings history

How has Surgery Partners' stock been impacted by Coronavirus?

Surgery Partners' stock was trading at $8.86 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SGRY stock has increased by 655.3% and is now trading at $66.92.
View which stocks have been most impacted by COVID-19

What guidance has Surgery Partners issued on next quarter's earnings?

Surgery Partners issued an update on its FY 2021 earnings guidance on Tuesday, June, 1st. The company provided EPS guidance of - for the period. The company issued revenue guidance of $2.20 billion-$2.23 billion, compared to the consensus revenue estimate of $2.23 billion.

What price target have analysts set for SGRY?

7 analysts have issued 12-month price targets for Surgery Partners' shares. Their forecasts range from $17.50 to $61.00. On average, they expect Surgery Partners' share price to reach $32.07 in the next twelve months. This suggests that the stock has a possible downside of 52.1%.
View analysts' price targets for Surgery Partners
or view top-rated stocks among Wall Street analysts.

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the following people:
  • Mr. Wayne Scott DeVeydt, Exec. Chairman (Age 51, Pay $434.53k)
  • Mr. J. Eric Evans, CEO & Director (Age 43, Pay $1.29M)
  • Mr. Thomas Francis Cowhey, Exec. VP & CFO (Age 49, Pay $672.4k)
  • Ms. Jennifer B. Baldock, Exec. VP, Chief Admin. & Devel. Officer (Age 50, Pay $551.7k)
  • Mr. George M. Goodwin, Pres of ASC Group (Age 60, Pay $573.71k)
  • Mr. Anthony W. Taparo, Chief Growth Officer (Age 55, Pay $540.81k)
  • Mr. Matt Petty, Sr. VP & Chief Information Officer
  • Ms. Roxanne Womack, Sr. VP & Chief Compliance Officer
  • Ms. Laura L. Brocklehurst, Sr. VP & Chief HR Officer (Age 51)
  • Mr. Bradley R. Owens, Pres of National Group (Age 51)

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners CEO Eric Evans on Eric Evans has an approval rating of 86% among Surgery Partners' employees.

Who are some of Surgery Partners' key competitors?

What other stocks do shareholders of Surgery Partners own?

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a number of retail and institutional investors. Top institutional investors include Clearbridge Investments LLC (6.08%), Price T Rowe Associates Inc. MD (4.55%), BlackRock Inc. (3.27%), Dimensional Fund Advisors LP (2.22%), Victory Capital Management Inc. (1.38%) and Federated Hermes Inc. (1.38%). Company insiders that own Surgery Partners stock include Anthony Taparo, George Goodwin, Jason Eric Evans, Jennifer Baldock, Teresa Deluca and Thomas F Cowhey.
View institutional ownership trends for Surgery Partners

Which institutional investors are selling Surgery Partners stock?

SGRY stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Bank of Montreal Can, Royce & Associates LP, Renaissance Technologies LLC, Polar Capital Holdings Plc, Citigroup Inc., Connacht Asset Management LP, and Clearbridge Investments LLC. Company insiders that have sold Surgery Partners company stock in the last year include Anthony Taparo, George Goodwin, Jennifer Baldock, Teresa Deluca, and Thomas F Cowhey.
View insider buying and selling activity for Surgery Partners
or view top insider-selling stocks.

Which institutional investors are buying Surgery Partners stock?

SGRY stock was acquired by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Victory Capital Management Inc., Federated Hermes Inc., Morgan Stanley, BlackRock Inc., Lisanti Capital Growth LLC, Goldman Sachs Group Inc., and Geode Capital Management LLC. Company insiders that have bought Surgery Partners stock in the last two years include Jason Eric Evans, and Teresa Deluca.
View insider buying and selling activity for Surgery Partners
or or view top insider-buying stocks.

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $66.92.

How much money does Surgery Partners make?

Surgery Partners has a market capitalization of $4.01 billion and generates $1.86 billion in revenue each year. The company earns $-116,100,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis.

How many employees does Surgery Partners have?

Surgery Partners employs 10,800 workers across the globe.

What is Surgery Partners' official website?

The official website for Surgery Partners is

Where are Surgery Partners' headquarters?

Surgery Partners is headquartered at 310 Seven Springs Way Suite 500, Brentwood TN, 37027.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]

This page was last updated on 6/21/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.